drugset / Trial / NCT02777970

Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar

NCT02777970

Phase 4 Completed 654 enrolled Menarini Group
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is aimed to evaluate the analgesic efficacy of TRAM.HCl/DKP.TRIS 75mg/25mg oral fixed drug combination in comparison with TRAM.HCl /paracetamol 75mg/650mg in the treatment of moderate to severe acute pain.

Timeline

Start
2016-04
Primary completion
2017-02-14
Completion
2017-02-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 650 mg Oral
Subject Dexketoprofen Small molecule 25 mg Oral
Subject Tramadol Other / unclassified 75 mg Oral

Indications

No indication recorded.